Correlation Between PDS Biotechnology and Imunon

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both PDS Biotechnology and Imunon at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PDS Biotechnology and Imunon into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PDS Biotechnology Corp and Imunon Inc, you can compare the effects of market volatilities on PDS Biotechnology and Imunon and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PDS Biotechnology with a short position of Imunon. Check out your portfolio center. Please also check ongoing floating volatility patterns of PDS Biotechnology and Imunon.

Diversification Opportunities for PDS Biotechnology and Imunon

-0.18
  Correlation Coefficient

Good diversification

The 3 months correlation between PDS and Imunon is -0.18. Overlapping area represents the amount of risk that can be diversified away by holding PDS Biotechnology Corp and Imunon Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Imunon Inc and PDS Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PDS Biotechnology Corp are associated (or correlated) with Imunon. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Imunon Inc has no effect on the direction of PDS Biotechnology i.e., PDS Biotechnology and Imunon go up and down completely randomly.

Pair Corralation between PDS Biotechnology and Imunon

Given the investment horizon of 90 days PDS Biotechnology Corp is expected to under-perform the Imunon. In addition to that, PDS Biotechnology is 2.13 times more volatile than Imunon Inc. It trades about -0.03 of its total potential returns per unit of risk. Imunon Inc is currently generating about 0.01 per unit of volatility. If you would invest  90.00  in Imunon Inc on December 11, 2024 and sell it today you would lose (1.00) from holding Imunon Inc or give up 1.11% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

PDS Biotechnology Corp  vs.  Imunon Inc

 Performance 
       Timeline  
PDS Biotechnology Corp 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days PDS Biotechnology Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Imunon Inc 

Risk-Adjusted Performance

Insignificant

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Imunon Inc are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Imunon may actually be approaching a critical reversion point that can send shares even higher in April 2025.

PDS Biotechnology and Imunon Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with PDS Biotechnology and Imunon

The main advantage of trading using opposite PDS Biotechnology and Imunon positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PDS Biotechnology position performs unexpectedly, Imunon can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Imunon will offset losses from the drop in Imunon's long position.
The idea behind PDS Biotechnology Corp and Imunon Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Complementary Tools

Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios